2016
DOI: 10.1097/bot.0000000000000614
|View full text |Cite
|
Sign up to set email alerts
|

Membrane Induced Osteogenesis in the Management of Posttraumatic Bone Defects

Abstract: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(20 citation statements)
references
References 28 publications
0
19
0
1
Order By: Relevance
“…The IM is carefully opened, the spacer is removed, and the membrane is filled with bone graft and repaired such that it encases the graft material. Over 4 to 12 months, the graft consolidates and becomes functionally integrated with the patient's skeleton 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…The IM is carefully opened, the spacer is removed, and the membrane is filled with bone graft and repaired such that it encases the graft material. Over 4 to 12 months, the graft consolidates and becomes functionally integrated with the patient's skeleton 4,5 …”
Section: Introductionmentioning
confidence: 99%
“…In our study, 85.7% (48/56) of the cases acquired bone union during the nal follow up. Compared with Azi's study [11], he acquired higher bone union rate (91%) with this technique. This could be explained by all study cases were large segmental defects.…”
Section: Discussionmentioning
confidence: 57%
“…The results of this procedure were assessed in a study of 33 patients with a total of 34 bone defects 5 . The mean age at the time of treatment was 33 years, and the mean defect size was 6.7 cm.…”
Section: Resultsmentioning
confidence: 99%
“…8-C) after introduction of the spacer into the bone defect. • Graft volume may be enlarged with allograft or biomaterials (demineralized bone matrix or tricalcium phosphate) and enriched with growth factors (bone morphogenetic protein or platelet-rich concentrate) [3][4][5]15 .…”
Section: Contraindicationsmentioning
confidence: 99%